Lin YC - Search Results

1

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.

Hsu PC, Huang CY, Lin YC, Lee SH, Chiu LC, Wu CE, Kuo SC, Ju JS, Huang AC, Ko HW, Wang CC, Yang CT. Hsu PC, et al. Among authors: lin yc. Front Oncol. 2023 Oct 3;13:1249106. doi: 10.3389/fonc.2023.1249106. eCollection 2023. Front Oncol. 2023. PMID: 37854677 Free PMC article.

2

Leptospirosis presenting with fever and pulmonary hemorrhage.

Lin YC, Lin MC, Yang CW, Tsai YH, Yang CT. Lin YC, et al. Among authors: lin mc. J Formos Med Assoc. 2005 Jan;104(1):50-3. J Formos Med Assoc. 2005. PMID: 15660179

3

WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.

Yang TM, Leu SW, Li JM, Hung MS, Lin CH, Lin YC, Huang TJ, Tsai YH, Yang CT. Yang TM, et al. Among authors: lin ch, lin yc. J Cancer Res Clin Oncol. 2009 Jul;135(7):919-24. doi: 10.1007/s00432-008-0527-7. Epub 2008 Dec 16. J Cancer Res Clin Oncol. 2009. PMID: 19085002

4

Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.

Hung MS, Lin YC, Mao JH, Kim IJ, Xu Z, Yang CT, Jablons DM, You L. Hung MS, et al. Among authors: lin yc. PLoS One. 2010 Jul 2;5(7):e11418. doi: 10.1371/journal.pone.0011418. PLoS One. 2010. PMID: 20625391 Free PMC article.

5

Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.

Lin YC, Lin CK, Tsai YH, Weng HH, Li YC, You L, Chen JK, Jablons DM, Yang CT. Lin YC, et al. Among authors: lin ck. Oncol Rep. 2010 Dec;24(6):1605-12. doi: 10.3892/or_00001024. Oncol Rep. 2010. PMID: 21042758

6

CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation.

Lin YC, Hung MS, Lin CK, Li JM, Lee KD, Li YC, Chen MF, Chen JK, Yang CT. Lin YC, et al. Among authors: lin ck. Cancer Biother Radiopharm. 2011 Jun;26(3):381-8. doi: 10.1089/cbr.2010.0917. Epub 2011 Jun 28. Cancer Biother Radiopharm. 2011. PMID: 21711111

7

Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model.

Hung MS, Xu Z, Chen Y, Smith E, Mao JH, Hsieh D, Lin YC, Yang CT, Jablons DM, You L. Hung MS, et al. Among authors: lin yc. Int J Oncol. 2013 Nov;43(5):1517-22. doi: 10.3892/ijo.2013.2087. Epub 2013 Sep 4. Int J Oncol. 2013. PMID: 24008396 Free PMC article.

8

Mapping gray matter reductions in obstructive sleep apnea: an activation likelihood estimation meta-analysis.

Weng HH, Tsai YH, Chen CF, Lin YC, Yang CT, Tsai YH, Yang CY. Weng HH, et al. Among authors: lin yc. Sleep. 2014 Jan 1;37(1):167-75. doi: 10.5665/sleep.3330. Sleep. 2014. PMID: 24470705 Free PMC article.

9

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations.

Chiu CH, Yang CT, Shih JY, Huang MS, Su WC, Lai RS, Wang CC, Hsiao SH, Lin YC, Ho CL, Hsia TC, Wu MF, Lai CL, Lee KY, Lin CB, Yu-Wung Yeh D, Chuang CY, Chang FK, Tsai CM, Perng RP, Chih-Hsin Yang J. Chiu CH, et al. Among authors: lin cb, lin yc. J Thorac Oncol. 2015 May;10(5):793-799. doi: 10.1097/JTO.0000000000000504. J Thorac Oncol. 2015. PMID: 25668120 Free article.

10

Gray matter atrophy in narcolepsy: An activation likelihood estimation meta-analysis.

Weng HH, Chen CF, Tsai YH, Wu CY, Lee M, Lin YC, Yang CT, Tsai YH, Yang CY. Weng HH, et al. Among authors: lin yc. Neurosci Biobehav Rev. 2015 Dec;59:53-63. doi: 10.1016/j.neubiorev.2015.03.009. Epub 2015 Mar 28. Neurosci Biobehav Rev. 2015. PMID: 25825285 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,279 results

Search Page